SK bioscienceLtd Balance Sheet Health
Financial Health criteria checks 3/6
SK bioscienceLtd has a total shareholder equity of ₩1,719.4B and total debt of ₩188.2B, which brings its debt-to-equity ratio to 10.9%. Its total assets and total liabilities are ₩2,047.6B and ₩328.2B respectively.
Key information
10.9%
Debt to equity ratio
₩188.21b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩1.34t |
| Equity | ₩1.72t |
| Total liabilities | ₩328.20b |
| Total assets | ₩2.05t |
Financial Position Analysis
Short Term Liabilities: A302440's short term assets (₩1,502.9B) exceed its short term liabilities (₩128.5B).
Long Term Liabilities: A302440's short term assets (₩1,502.9B) exceed its long term liabilities (₩199.7B).
Debt to Equity History and Analysis
Debt Level: A302440 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A302440's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A302440's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A302440's interest payments on its debt are well covered by EBIT.